HELP HEAL YOUR SKIN FROM WITHIN

Learn how DUPIXENT can help you stay one step ahead of your uncontrolled moderate-to-severe eczema (atopic dermatitis).

How Does DUPIXENT Work?

How Does DUPIXENT Help Heal Skin From Within?

DUPIXENT, a biologic, is a specialty medicine made inside living cells. It is processed in the body differently than oral medicines (pills) or steroids. In order to be effective and work in the body properly, most biologics are injectable medicines due to their size and the unique way they are made. DUPIXENT works by targeting an underlying source of inflammation that could be a root cause of your eczema. It helps heal your skin from within for noticeably clearer skin and less itch.

Track your progress to monitor changes over time.

DUPIXENT works from the inside, targeting an underlying source of inflammation.

DUPIXENT may help to heal the skin from within by targeting a source of inflammation that could be a root cause of eczema. DUPIXENT may help reduce this inflammation and the signs and symptoms of eczema to help make skin noticeably clearer. DUPIXENT is not an immunosuppressant and does not require routine blood monitoring. 

Watch the video to see what happens beneath the skin and how DUPIXENT works to help manage your symptoms.

Transcript

DUPIXENT Clinical Trial Results

Results in Adults

TRIAL RESULTS: DUPIXENT + TOPICAL

CORTICOSTEROIDS (TCS) vs TCS ONLY

Long term results from a 52-week clinical trial in 421 patients with uncontrolled moderate-to-severe eczema:

CLEAR OR ALMOST CLEAR SKIN

AT 16 WEEKS

39% taking DUPIXENT + TCS vs 12% using TCS only

LONG-LASTING CLEARER SKIN

AT 16 AND 52 WEEKS

22% taking DUPIXENT + TCS vs 7% using TCS only

FAST ITCH RELIEF

AS SOON AS 2 WEEKS

18% taking DUPIXENT + TCS vs 8% using TCS only

SIGNIFICANT ITCH REDUCTION

AT 16 WEEKS

59% taking DUPIXENT +TCS vs 20% using TCS only

ITCH RELIEF THAT LASTS

AT 52 WEEKS

51% taking DUPIXENT + TCS vs 13% using TCS only

SAFETY RESULTS:
The most common side effects observed in clinical trials were injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, cold sores in the mouth or on the lips, and high count of a certain white blood cell (eosinophilia).

Long-term safety results for adults continuing on DUPIXENT in the extension study for nearly 5 years were consistent with the adult clinical trials.

Use the slider to view these before and after results with 16 weeks of treatment with DUPIXENT. Real patient shown. Additional factors (including possible use of other treatments) may have impacted results. Individual results may vary.

Click and drag
to see results

Results in Teens (Ages 12-17 Years)

TRIAL RESULTS: DUPIXENT vs PLACEBO*

Results from a 16-week trial in 251 patients ages 12-17 years with uncontrolled moderate-to-severe eczema:

 

12X SAW CLEAR OR ALMOST
CLEAR SKIN

  • 24% vs 2% not taking DUPIXENT (placebo)


~7X EXPERIENCED ITCH RELIEF

  • 37% vs 5% not taking DUPIXENT (placebo)

NEARLY HALF OF TEENS SAW

≥75% CLEARER SKIN

  • 42% vs 8% in those not taking DUPIXENT (placebo)

SOME EVEN SAW

≥90% CLEARER SKIN

  • 23% vs 2% not taking DUPIXENT (placebo)
  • YOU CAN TAKE DUPIXENT WITH OR WITHOUT A TOPICAL CORTICOSTEROID (TCS)

*A treatment that appears to be real but contains no medicine.

SAFETY RESULTS:
Long-term safety results for teens continuing on DUPIXENT in the pediatric extension study through 1 year were consistent with the adult clinical trials.

Use the slider to view these before and after results of an actual 12-year-old patient after 16 weeks of treatment with DUPIXENT in a clinical trial. This patient did not meet clinical trial criteria for clear or almost clear skin at 16 weeks. Individual results may vary.

Click and drag
to see results

Results in Children (Ages 6-11 Years)

TRIAL RESULTS: DUPIXENT + TCS vs TCS ONLY

Results from a 16-week clinical trial with 367 patients ages 6-11 years with uncontrolled moderate-to-severe eczema:


>2X SAW CLEAR OR ALMOST CLEAR SKIN

  • 30% on 300 mg every 4 weeks + TCS vs 13% on TCS only
  • 39% on 200 mg every 2 weeks + TCS vs 10% on TCS only


~4.5X HAD LESS ITCH

  • 54% on 300 mg every 4 weeks + TCS vs 12% on TCS only
  • 61% on 200 mg every 2 weeks + TCS vs 13% on TCS only

MORE THAN HALF OF CHILDREN SAW

≥75% CLEARER SKIN

  • 75% on 300 mg every 4 weeks + TCS vs 28% on TCS only
  • 75% on 200 mg every 2 weeks + TCS vs 26% on TCS only

YOUR HEALTHCARE PROVIDER WILL TELL YOU HOW MUCH DUPIXENT TO INJECT AND HOW OFTEN.

  • YOU CAN TAKE DUPIXENT WITH OR WITHOUT A TOPICAL CORTICOSTEROID (TCS)

SAFETY RESULTS:
Long-term safety results for children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials.

Children who weighed 66 lb or more received DUPIXENT 200 mg every 2 weeks after an initial loading dose of 400 mg (two, 200-mg injections), and children who weighed less than 66 lb received DUPIXENT 300 mg every 4 weeks after an initial loading dose of 600 mg (two, 300-mg injections). Your healthcare provider will tell you how much DUPIXENT to inject and how often.

Use the slider to view before and after results of an actual 10-year-old patient after 16 weeks of treatment with DUPIXENT and a topical steroid in a phase 3 clinical trial. A clinical responder was defined as a patient achieving IGA 0 or 1 (clear or almost clear skin). Individual results may vary.

Click and drag
to see results

Results in Young Children (Ages 6 Months-5 Years)

TRIAL RESULTS: DUPIXENT + TCS vs TCS ONLY

Results from a 16-week clinical trial in 162 patients ages 6 months to 5 years with uncontrolled moderate-to-severe eczema:


7X SAW CLEAR OR ALMOST
CLEAR SKIN

  • 28% on DUPIXENT + TCS vs 4% on TCS only


~5X HAD LESS ITCH

  • 48% on DUPIXENT + TCS vs 9% on TCS only

 

HALF OF YOUNG CHILDREN SAW

≥75% CLEARER SKIN

  • 53% on DUPIXENT + TCS vs 11% on TCS only
  • YOU CAN TAKE DUPIXENT WITH OR WITHOUT A TOPICAL CORTICOSTEROID (TCS)

SAFETY RESULTS:
Long-term safety results in young children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.

Common Concerns

“No Treatment Will Work for Me.”

Not everyone will respond the same way to treatment. But one way to know how you’re responding to treatment is to track your progress. You can write down your symptoms when you notice them. You could also take pictures of eczema patches regularly. Remember, eczema can look different in individuals depending on skin tone, and the severity of symptoms may vary.

Consider using a journal, such as your DUPIXENT MyWay Patient Journal, to keep track of all your symptoms so you can share more information with your healthcare provider. Together, you can ensure that you get the most from your treatment. If you haven’t received a journal, or have misplaced it, call 1-844-DUPIXENT (1-844-387-4936), option 1 to request one.

“My Treatment Isn’t Working as Fast as I Hoped.”

It’s important to stick with your treatment as prescribed, as results may vary and changes in symptoms may happen gradually.

"I Don’t Understand How It Works."

DUPIXENT works by targeting a key source of inflammation under the skin that contributes to an overactive immune system. An overactive immune system leads to more inflammation than normal in the body, contributing to the symptoms you see and feel on the surface of your skin.

Frequently Asked Questions

About DUPIXENT

DUPIXENT works with your body’s immune system to help reduce inflammation contributing to your eczema, which may help reduce your moderate-to-severe eczema symptoms and may give you noticeably clearer skin.

DUPIXENT works by targeting an underlying source of inflammation that can be a root cause of your moderate-to-severe eczema.

DUPIXENT has not been studied with every medication that’s available. Tell your healthcare provider about all of the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements, before starting DUPIXENT.

DUPIXENT can be used with or without topical corticosteroids.

Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you’re taking oral, topical, or inhaled corticosteroid medicines and if you have atopic dermatitis and asthma and use an asthma medicine. Do not change or stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back.

You should not receive a “live vaccine” right before and during treatment with DUPIXENT.

Speak with your healthcare provider before making any change to your treatment regimen.

There are no known foods you should avoid while taking DUPIXENT.

If you suspect a side effect with a particular food, notify your healthcare provider.

Be sure to speak with your healthcare provider.

DUPIXENT works by blocking two proteins that contribute to a type of inflammation that plays a major role in atopic dermatitis.

DUPIXENT affects the body’s immune system to reduce the inflammation associated with moderate-to-severe eczema, which may reduce symptoms such as rash, redness, and itch. It is not known if DUPIXENT can affect the immune response to parasitic (helminth) infections.

How to Take DUPIXENT

Use DUPIXENT exactly as prescribed by your healthcare provider. Your healthcare provider will tell you how much DUPIXENT to inject and how often you inject it. The recommended dose is specified below. DUPIXENT can be used with or without topical corticosteroids.

  • Adults ages 18+ and at any weight will have an initial loading dose of 600 mg (two, 300-mg injections) followed by one, 300-mg injection every 2 weeks
  • Children and teens ages 6-17 years and weighing 33 lb to under 66 lb will have an initial loading dose of 600 mg (two, 300-mg injections) followed by one, 300-mg injection every 4 weeks
  • Children and teens ages 6-17 years and weighing 66 lb to under 132 lb will have an initial loading dose of 400 mg (two, 200-mg injections) followed by one, 200-mg injection every 2 weeks
  • Children and teens ages 6-17 years and weighing 132 lb or more will have an initial loading dose of 600 mg (two, 300-mg injections) followed by one, 300-mg injection every 2 weeks
  • Children ages 6 months-5 years weighing 11 lb to under 33 lb will be given one, 200-mg injection every 4 weeks, with no initial loading dose recommended
  • Children ages 6 months-5 years weighing 33 lb to under 66 lb will be given one, 300-mg injection every 4 weeks, with no initial loading dose recommended

Setting a routine may help you remember to take DUPIXENT as prescribed.

No, take DUPIXENT exactly as prescribed by your healthcare provider.

Moderate-to-severe eczema is a chronic disease with no known cure.

Each person may respond differently to DUPIXENT. It’s possible that your symptoms could return if you stop taking DUPIXENT.

Speak with your healthcare provider before you decide to stop treatment or if you have questions regarding how long you’ll need to take DUPIXENT.

  • If your dose schedule is every other week and you miss a dose of DUPIXENT: Give the DUPIXENT injection within 7 days from the missed dose, then continue with your original schedule. If the missed dose is not given within 7 days, wait until the next scheduled dose to give your DUPIXENT injection.
  • If your dose schedule is every 4 weeks and you miss a dose of DUPIXENT: Give the DUPIXENT injection within 7 days from the missed dose, then continue with your original schedule. If the missed dose is not given within 7 days, start a new every 4 week dose schedule from the time you remember to take your DUPIXENT injection.

Side Effects of DUPIXENT

DUPIXENT can cause serious side effects, including:

  • Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue, or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, joint pain, general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your stomach-area.
  • Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Your healthcare provider may send you to an ophthalmologist for an eye exam if needed.
  • Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Talk with your healthcare provider about the benefits and the risks of taking DUPIXENT.

The most common side effects in patients with eczema include injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, cold sores in your mouth or on your lips, and high count of a certain white blood cell (eosinophilia).

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Talk with your healthcare provider about the benefits and risks of taking DUPIXENT.

It’s important to tell your healthcare provider about any side effects that you may be experiencing.

Before starting treatment, you or your caregiver should receive training from your healthcare provider on the right way to prepare and inject DUPIXENT under the skin. Carefully follow the Instructions for Use, which include choosing the initial injection site, as well as a different injection site each time you inject DUPIXENT. Instructions for Use can be found here and are included in your shipment of DUPIXENT.

Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider. In children 12 years of age and older, it’s recommended DUPIXENT be administered by or under supervision of an adult. In children 6 months to less than 12 years of age, DUPIXENT should be given by a caregiver.

Some patients taking DUPIXENT have reported cold sores, which can be caused by infection with a virus known as herpes simplex.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Storage and Travel

DUPIXENT syringes should be stored in the refrigerator between 36 °F and 46 °F (2 °C and 8 °C). They should be kept in their original carton to protect them from light.

After removal from the refrigerator, DUPIXENT must be used within 14 days or discarded. If you remove DUPIXENT from the refrigerator for 20-30 minutes, and do not use, you can and should put it back in the refrigerator.

DUPIXENT may be kept at room temperature up to 77 °F (25 °C) for a maximum of 14 days.

You can travel with DUPIXENT; check with your airline if you have any specific questions or concerns.

Other Questions

It is not known what exactly causes moderate-to-severe eczema, although researchers believe a combination of genes and environment is involved.

The immune system of someone with moderate-to-severe eczema may produce more inflammation than normal, which contributes to causing the red, itchy skin with rash.

Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:

  • have eye problems.
  • have a parasitic (helminth) infection.
  • are scheduled to receive any vaccinations. You should not receive a “live vaccine” right before and during treatment with DUPIXENT.
  • are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
    • A pregnancy registry for women who take DUPIXENT during pregnancy collects information about the health of you and your baby. To enroll or get more information call 1-877-311-8972 or go to https://mothertobaby.org/ongoing-study/dupixent/.
  • are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines; have asthma and use an asthma medicine; or have atopic dermatitis, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, or prurigo nodularis and also have asthma. Do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back.